As of 2025-07-04, the EV/EBITDA ratio of AC Immune SA (ACIU) is -3.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACIU's latest enterprise value is 189.34 mil USD. ACIU's TTM EBITDA according to its financial statements is -49.46 mil USD. Dividing these 2 quantities gives us the above ACIU EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 8.2x | 7.6x |
| Forward P/E multiples | 6.8x - 9.3x | 8.8x |
| Fair Price | (4.01) - (4.90) | (4.87) |
| Upside | -293.6% - -336.5% | -335.3% |
| Date | EV/EBITDA |
| 2025-07-02 | -2.98 |
| 2025-07-01 | -2.91 |
| 2025-06-30 | -2.99 |
| 2025-06-27 | -2.96 |
| 2025-06-26 | -3.09 |
| 2025-06-25 | -3.06 |
| 2025-06-24 | -3.12 |
| 2025-06-23 | -2.67 |
| 2025-06-20 | -2.75 |
| 2025-06-18 | -2.91 |
| 2025-06-17 | -2.82 |
| 2025-06-16 | -2.85 |
| 2025-06-13 | -2.86 |
| 2025-06-12 | -3.06 |
| 2025-06-11 | -3.14 |
| 2025-06-10 | -3.27 |
| 2025-06-09 | -3.11 |
| 2025-06-06 | -3.01 |
| 2025-06-05 | -2.51 |
| 2025-06-04 | -2.41 |
| 2025-06-03 | -2.38 |
| 2025-06-02 | -2.37 |
| 2025-05-30 | -2.47 |
| 2025-05-29 | -2.45 |
| 2025-05-28 | -2.43 |
| 2025-05-27 | -2.44 |
| 2025-05-23 | -2.44 |
| 2025-05-22 | -2.45 |
| 2025-05-21 | -2.38 |
| 2025-05-20 | -2.54 |
| 2025-05-19 | -2.52 |
| 2025-05-16 | -2.47 |
| 2025-05-15 | -2.25 |
| 2025-05-14 | -2.18 |
| 2025-05-13 | -2.25 |
| 2025-05-12 | -2.34 |
| 2025-05-09 | -2.43 |
| 2025-05-08 | -2.39 |
| 2025-05-07 | -2.39 |
| 2025-05-06 | -2.33 |
| 2025-05-05 | -2.47 |
| 2025-05-02 | -2.49 |
| 2025-05-01 | -2.41 |
| 2025-04-30 | -2.51 |
| 2025-04-29 | -2.46 |
| 2025-04-28 | -2.46 |
| 2025-04-25 | -2.36 |
| 2025-04-24 | -2.39 |
| 2025-04-23 | -2.26 |
| 2025-04-22 | -2.13 |